In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans

被引:46
作者
Hougardy, Jean-Michel
Verscheure, Virginie
Locht, Camille
Mascart, Franqoise [1 ]
Mascart, Francoise
机构
[1] Hop Erasme, Immunol Clin, 808 route de Lennik, B-1070 Brussels, Belgium
[2] Univ Libre Bruxelles, Lab Vaccinol & Mucosal Immun, Brussels, Belgium
[3] INSERM, F-59045 Lille, France
[4] Inst Pasteur, F-59019 Lille, France
关键词
Tuberculosis; human regulatory T cells; FOXP3; CD127;
D O I
10.1016/j.micinf.2007.06.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(high)FOXP3(+) regulatory T (Treg) cells have recently been found at elevated levels in the peripheral blood of tuberculosis patients, compared to Mycobacterium tuberculosis latently infected (LTB1) healthy individuals and non-infected controls. Here, we show that CD4(+)CD25(high)FOXP3(+) T lymphocytes can be expanded in vitro from peripheral blood mononuclear cells (PBMC) of LTBI individuals, but not of uninfected controls by incubating them with BCG in the presence of TGF-beta. These expanded cells from the PBMC of LTBI subjects expressed CTLA-4, GITR and OX-40, but were CD127(low/-) and have therefore the phenotype of Treg cells. In addition, they inhibited in a dose-dependant manner the proliferation of freshly isolated mononuclear cells in response to polyclonal stimulation, indicating that they are functional Treg lymphocytes. In contrast, incubation of the PBMC with BCG alone preferentially induced activated CD4(+) T cells, expressing CD25 and/or CD69 and secreting IFN-gamma. These results show that CD4(+)CD25(high)FOXP3(+) Treg cells can be expanded or induced in the peripheral blood of LTBI individuals in conditions known to predispose to progression towards active tuberculosis and may therefore play an important role in the pathogenesis of the disease. (C) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1325 / 1332
页数:8
相关论文
共 30 条
[1]   Origin of regulatory T cells with known specificity for antigen [J].
Apostolou, I ;
Sarukhan, A ;
Klein, L ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2002, 3 (08) :756-763
[2]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[3]   IL-10-producing T cells suppress immune responses in anergic tuberculosis patients [J].
Boussiotis, VA ;
Tsai, EY ;
Yunis, EJ ;
Thim, S ;
Delgado, JC ;
Dascher, CC ;
Berezovskaya, A ;
Rousset, D ;
Reynes, JM ;
Goldfeld, AE .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09) :1317-1324
[4]   Role of regulatory T cells in human diseases [J].
Chatila, TA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (05) :949-959
[5]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[6]   Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis [J].
Demissie, A ;
Leyten, EMS ;
Abebe, M ;
Wassie, L ;
Aseffa, A ;
Abate, G ;
Fletcher, H ;
Owiafe, P ;
Hill, PC ;
Brookes, R ;
Ottenhoff, THM ;
Andersen, P ;
Doherty, TM .
CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (02) :179-186
[7]   Global epidemiology of tuberculosis [J].
Dye, C .
LANCET, 2006, 367 (9514) :938-940
[8]  
Fine PEM, 1996, LANCET, V348, P17, DOI 10.1016/S0140-6736(96)02166-6
[9]   VARIATION IN PROTECTION BY BCG - IMPLICATIONS OF AND FOR HETEROLOGOUS IMMUNITY [J].
FINE, PEM .
LANCET, 1995, 346 (8986) :1339-1345
[10]   Transforming growth factor β1 at clinical onset of Type 1 diabetes mellitus.: A pilot study [J].
Flores, L ;
Näf, S ;
Hernáez, R ;
Conget, I ;
Gomis, R ;
Esmatjes, E .
DIABETIC MEDICINE, 2004, 21 (08) :818-822